Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06396845

Enrollment

505

Registered

2024-05-02

Start date

2019-01-01

Completion date

2024-01-03

Last updated

2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Resection for Rectal Cancer, Laparoscopic, Robotic

Brief summary

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Interventions

PROCEDURErobotic surgery

robotic surgery

PROCEDURElaparoscopic surgery

laparoscopic surgery

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

55 Years to 85 Years

Inclusion criteria

The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data.

Exclusion criteria

patients with other malignant tumors besides rectal cancer, benign disease surgery, and emergency surgery.

Design outcomes

Primary

Measure	Time frame	Description
postoperative recurrence rate	2018-2024	postoperative recurrence rate

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026